Kevin D Ballard1, Robert M Duguid2, Craig W Berry2, Priyankar Dey3, Richard S Bruno3, Rose Marie Ward2, Kyle L Timmerman2. 1. Department of Kinesiology and Health, College of Education, Health and Society, Miami University, 420 South Oak Street, Oxford, OH, 45056, USA. ballarkd@miamioh.edu. 2. Department of Kinesiology and Health, College of Education, Health and Society, Miami University, 420 South Oak Street, Oxford, OH, 45056, USA. 3. Human Nutrition Program, College of Education and Human Ecology, The Ohio State University, Columbus, OH, 43210, USA.
Abstract
INTRODUCTION:Acute aerobic exercise prevents sitting-induced impairment of flow-mediated dilation (FMD). Further, evidence suggests that sitting-induced impairment of FMD occurs via an oxidative stress-dependent mechanism that disrupts endothelial function. PURPOSE: We hypothesized that acute aerobic exercise would prevent impairment of femoral artery FMD by limiting oxidative stress responses that increase endothelin-1 (ET-1) levels and disrupt nitric oxide (NO) status. METHODS: In a randomized, cross-over study, healthy men (n = 11; 21.2 ± 1.9 years) completed two 3 h sitting trials that were preceded by 45 min of either quiet rest (REST) or a single bout of continuous treadmill exercise (65% maximal oxygen consumption) (EX). Superficial femoral artery FMD, plasma glucose, malondialdehyde (MDA), ET-1, arginine (ARG) and its related metabolites [homoarginine (HA), asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA)] were assessed at baseline, 1 h following EX (or REST) (0 h), and at 1 h intervals during 3 h of uninterrupted sitting. Data were analyzed using repeated measures ANOVA. RESULTS: During REST, femoral artery FMD declined from baseline (2.6 ± 1.8%) at 1, 2, and 3 h of sitting and resting shear rate decreased at 3 h. In contrast, when sitting was preceded by EX, femoral artery FMD (2.7 ± 2.0%) and resting shear rate responses were unaffected. No between trial differences were detected for plasma glucose, MDA, ET-1, ARG, HA, ADMA, or SDMA. CONCLUSION:Prior aerobic exercise prevented the decline in femoral artery FMD that is otherwise induced by prolonged sitting independent of changes in oxidative stress, ET-1, and NO status.
RCT Entities:
INTRODUCTION: Acute aerobic exercise prevents sitting-induced impairment of flow-mediated dilation (FMD). Further, evidence suggests that sitting-induced impairment of FMD occurs via an oxidative stress-dependent mechanism that disrupts endothelial function. PURPOSE: We hypothesized that acute aerobic exercise would prevent impairment of femoral artery FMD by limiting oxidative stress responses that increase endothelin-1 (ET-1) levels and disrupt nitric oxide (NO) status. METHODS: In a randomized, cross-over study, healthy men (n = 11; 21.2 ± 1.9 years) completed two 3 h sitting trials that were preceded by 45 min of either quiet rest (REST) or a single bout of continuous treadmill exercise (65% maximal oxygen consumption) (EX). Superficial femoral artery FMD, plasma glucose, malondialdehyde (MDA), ET-1, arginine (ARG) and its related metabolites [homoarginine (HA), asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA)] were assessed at baseline, 1 h following EX (or REST) (0 h), and at 1 h intervals during 3 h of uninterrupted sitting. Data were analyzed using repeated measures ANOVA. RESULTS: During REST, femoral artery FMD declined from baseline (2.6 ± 1.8%) at 1, 2, and 3 h of sitting and resting shear rate decreased at 3 h. In contrast, when sitting was preceded by EX, femoral artery FMD (2.7 ± 2.0%) and resting shear rate responses were unaffected. No between trial differences were detected for plasma glucose, MDA, ET-1, ARG, HA, ADMA, or SDMA. CONCLUSION: Prior aerobic exercise prevented the decline in femoral artery FMD that is otherwise induced by prolonged sitting independent of changes in oxidative stress, ET-1, and NO status.
Authors: Charles E Matthews; Kong Y Chen; Patty S Freedson; Maciej S Buchowski; Bettina M Beech; Russell R Pate; Richard P Troiano Journal: Am J Epidemiol Date: 2008-02-25 Impact factor: 4.897
Authors: Takuma Morishima; Robert M Restaino; Lauren K Walsh; Jill A Kanaley; Paul J Fadel; Jaume Padilla Journal: Am J Physiol Heart Circ Physiol Date: 2016-05-27 Impact factor: 4.733
Authors: Jennifer R Vranish; Benjamin E Young; Jasdeep Kaur; Jordan C Patik; Jaume Padilla; Paul J Fadel Journal: Am J Physiol Heart Circ Physiol Date: 2017-01-27 Impact factor: 4.733
Authors: Carol Ewing Garber; Bryan Blissmer; Michael R Deschenes; Barry A Franklin; Michael J Lamonte; I-Min Lee; David C Nieman; David P Swain Journal: Med Sci Sports Exerc Date: 2011-07 Impact factor: 5.411
Authors: M Kooijman; D H J Thijssen; P C E de Groot; M W P Bleeker; H J M van Kuppevelt; D J Green; G A Rongen; P Smits; M T E Hopman Journal: J Physiol Date: 2007-12-20 Impact factor: 5.182
Authors: Christine Susara du Plooy; Catharina Martha Cornelia Mels; Hugo Willem Huisman; Ruan Kruger Journal: Hypertens Res Date: 2016-09-29 Impact factor: 3.872
Authors: Craig Paterson; Simon Fryer; Keeron Stone; Gabriel Zieff; Louise Turner; Lee Stoner Journal: Sports Med Date: 2021-12-21 Impact factor: 11.928
Authors: Craig Paterson; Simon Fryer; Gabriel Zieff; Keeron Stone; Daniel P Credeur; Bethany Barone Gibbs; Jaume Padilla; John K Parker; Lee Stoner Journal: Sports Med Date: 2020-11 Impact factor: 11.136
Authors: Wojciech Wołyniec; Katarzyna Kasprowicz; Joanna Giebułtowicz; Natalia Korytowska; Katarzyna Zorena; Maria Bartoszewicz; Patrycja Rita-Tkachenko; Marcin Renke; Wojciech Ratkowski Journal: Int J Environ Res Public Health Date: 2019-10-28 Impact factor: 3.390